Discovering New Ways to Overcome Treatment Resistance in Triple-Negative MBC - Metastatic Breast Cancer Trial Talk

Research News

Treatment resistance is when cancer does not respond to a drug. Cancer, including triple-negative MBC, often becomes resistant to a particular treatment over time. Alternatively, resistance may be present before treatment begins. Researchers are working to understand why resistance happens and to find new ways to overcome resistance. An important step in understanding treatment resistance is to identify biomarkers in people with treatment-resistant triple-negative breast cancer in clinical trials. 

Read below to learn about current research efforts to overcome treatment resistance in triple-negative MBC. 

Treatment Resistance in Triple-Negative MBC 
MBC Clinical Trials 


Last Modified on January 2, 2024



for past articles or specific information.